Article
Therapeutic decisions for glaucoma patients weigh benefits
Chicago-IOP control remains the basis for primary treatment of glaucoma, but there have been some recent changes in the medical and surgical arenas. Now, a prostaglandin analogue is often used instead of a beta-blocker as first-line therapy, selective laser trabeculoplasty (SLT) has emerged as another option for primary laser surgery, and meanwhile, there is growing patient interest in complementary medicine alternatives.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
